Principal Financial Group’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $44.8K | Sell |
|
|||||
|
2024
Q1 | $175K | Sell |
|
|||||
|
2023
Q4 | $100K | Sell |
|
|||||
|
2023
Q3 | $60.5K | Buy |
|
|||||
|
2023
Q2 | $122K | Buy |
|
|||||
|
2023
Q1 | $131K | Sell |
|
|||||
|
2022
Q4 | $249K | Buy |
|
|||||
|
2022
Q3 | $521K | Sell |
|
|||||
|
2022
Q2 | $588K | Sell |
|
|||||
|
2022
Q1 | $999K | Sell |
|
|||||
|
2021
Q4 | $4.08M | Sell |
|
|||||
|
2021
Q3 | $4.76M | Sell |
|
|||||
|
2021
Q2 | $14.4M | Sell |
|
|||||
|
2021
Q1 | $17.6M | Buy |
|
|||||
|
2020
Q4 | $3.28M | Buy |
|
|||||
|
2020
Q3 | $1.07M | Buy |
|
|||||
|
2020
Q2 | $919K | Buy |
|
|||||
|
2020
Q1 | $221K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $159K | Buy |
|
|||||
|
2019
Q2 | $201K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $529K | Sell |
|
|||||
|
2015
Q4 | $1.18M | Hold |
|
|||||
|
2015
Q3 | $1.87M | Buy |
|
|||||
|
2015
Q2 | $2.27M | Buy |
|
|||||
|
2015
Q1 | $1.02M | Buy |
|
|||||
|
2014
Q4 | $1.04M | Buy |
|
|||||
|
2014
Q3 | $1.04M | Sell |
|
|||||
|
2014
Q2 | $1.29M | Hold |
|
|||||
|
2014
Q1 | $1.99M | Buy |
|
|||||
|
2013
Q4 | $1.27M | Buy |
|